,"On November 17, 2025, the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion open for public comment regarding Butylated Hydroxyanisole (BHA), with the deadline for comments set for January 19, 2026. The SCCS assessed the use of BHA in cosmetic products, considering technical and scientific progress, available literature, in silico tools, and expert judgment, with particular attention to potential endocrine disrupting properties. - The SCCS concluded that the use of BHA in leave-on and rinse-off cosmetic products up to a concentration of 0.07% is considered safe for dermal application. The assessment specifically addresses dermal use and is not applicable to oral care products or cosmetic products that may lead to inhalation exposure. The committee identified no specific concerns for human health from dermal exposure to BHA within the specified concentration limit. However, the opinion does not cover risks associated with oral or inhalation exposure routes, nor does it address the safety of BHA for the environment, as these aspects fall outside the current mandate. Overall, the SCCS opinion affirms the safety of BHA in dermally applied cosmetic products up to 0.07%, while emphasizing the limitations of the assessment regarding other exposure routes and environmental impact."
Consumer News Region